shutterstock_2

AstraZeneca continues to ramp up COVID-19 vaccine production with new CMO partnership

pharmafile | June 25, 2020 | News story | Manufacturing and Production AstraZeneca, COVID-19, Vaccine 

AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University of Oxford and currently being tested in human trials across a number of trials across the UK, with its latest partnership signed with Scottish firm Symbiosis Pharmaceutical Services.

Under the agreement, the contract manufacturing organisation will offer “fast-track” to its sterile vaccine drug product manufacturing capacity in order to supply doses of the vaccine to clinical trial sites for further research.

It’s the latest in a line of deals sealed by AZ in the past months, after securing funding from the US and UK Governments in exchange for securing reserves of the vaccine. The company plans to manufacture two billion doses by 2021.

“Our team is immensely proud to be able to make a highly meaningful contribution to the global fight against COVID-19 and the urgent efforts to develop a successful vaccine” commented Colin MacKay, founder and CEO of Symbiosis. “With many years of direct experience manufacturing medicines and vaccines of this nature for clinical trials and commercial markets, we are delighted to be able to leverage our expertise and competitive strengths to accelerate the development of this vaccine for AstraZeneca and to add value to the project.”

Advertisement

Matt Fellows

Related Content

drug-trials

BioNet receives positive EMA opinion on new pertussis vaccine

BioNet has received a positive opinion from the Committee for Medicinal Products for Human Use …

Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON

Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based …

covid_cell

COVID-19 vaccine eligibility creates challenges for UK pharmacies

Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …

The Gateway to Local Adoption Series

Latest content